KING PHARMACEUTICALS Stock Forecast - Accumulation Distribution
| KG Stock | 24.86 0.07 0.28% |
KING Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of KING PHARMACEUTICALS's historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, KING PHARMACEUTICALS's Asset Turnover is most likely to increase slightly in the upcoming years. . The KING PHARMACEUTICALS's current Net Income Applicable To Common Shares is estimated to increase to about 130.6 M, while Common Stock Shares Outstanding is projected to decrease to roughly 6.2 M. | Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 466.52 | 0.0028 |
| Check KING PHARMACEUTICALS Volatility | Backtest KING PHARMACEUTICALS | Information Ratio |
KING PHARMACEUTICALS Trading Date Momentum
| On July 24 2025 KING PHARMACEUTICALS INC was traded for 24.86 at the closing time. The highest price during the trading period was 24.86 and the lowest recorded bid was listed for 24.79 . There was no trading activity during the period 0.0. Lack of trading volume on July 24, 2025 did not cause price change. The trading delta at closing time to the current price is 0.28% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare KING PHARMACEUTICALS to competition |
Other Forecasting Options for KING PHARMACEUTICALS
For every potential investor in KING, whether a beginner or expert, KING PHARMACEUTICALS's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. KING Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in KING. Basic forecasting techniques help filter out the noise by identifying KING PHARMACEUTICALS's price trends.KING PHARMACEUTICALS Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with KING PHARMACEUTICALS stock to make a market-neutral strategy. Peer analysis of KING PHARMACEUTICALS could also be used in its relative valuation, which is a method of valuing KING PHARMACEUTICALS by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
KING PHARMACEUTICALS INC Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of KING PHARMACEUTICALS's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of KING PHARMACEUTICALS's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
KING PHARMACEUTICALS Market Strength Events
Market strength indicators help investors to evaluate how KING PHARMACEUTICALS stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading KING PHARMACEUTICALS shares will generate the highest return on investment. By undertsting and applying KING PHARMACEUTICALS stock market strength indicators, traders can identify KING PHARMACEUTICALS INC entry and exit signals to maximize returns.
KING PHARMACEUTICALS Risk Indicators
The analysis of KING PHARMACEUTICALS's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in KING PHARMACEUTICALS's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting king stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.4 | |||
| Semi Deviation | 5.25 | |||
| Standard Deviation | 8.42 | |||
| Variance | 70.96 | |||
| Downside Variance | 35.27 | |||
| Semi Variance | 27.52 | |||
| Expected Short fall | (6.39) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
| VALE | Vale SA ADR | |
| EGY | Vaalco Energy | |
| CMCSA | Comcast Corp | |
| BTE | Baytex Energy Corp | |
| SOXS | Direxion Daily Semiconductor |
Check out Historical Fundamental Analysis of KING PHARMACEUTICALS to cross-verify your projections. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of KING PHARMACEUTICALS. If investors know KING will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about KING PHARMACEUTICALS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.03 |
The market value of KING PHARMACEUTICALS INC is measured differently than its book value, which is the value of KING that is recorded on the company's balance sheet. Investors also form their own opinion of KING PHARMACEUTICALS's value that differs from its market value or its book value, called intrinsic value, which is KING PHARMACEUTICALS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because KING PHARMACEUTICALS's market value can be influenced by many factors that don't directly affect KING PHARMACEUTICALS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between KING PHARMACEUTICALS's value and its price as these two are different measures arrived at by different means. Investors typically determine if KING PHARMACEUTICALS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, KING PHARMACEUTICALS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.